CL/MAB 231 Trademark

Trademark Overview


On Monday, September 30, 1991, a trademark application was filed for CL/MAB 231 with the United States Patent and Trademark Office. The USPTO has given the CL/MAB 231 trademark a serial number of 74208192. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, January 31, 2004. This trademark is owned by Synbiotics Corporation. The CL/MAB 231 trademark is filed in the Pharmaceutical Products category with the following description:

canine lymphoma monoclonal antibody

General Information


Serial Number74208192
Word MarkCL/MAB 231
Filing DateMonday, September 30, 1991
Status710 - CANCELLED - SECTION 8
Status DateSaturday, January 31, 2004
Registration Number1767893
Registration DateTuesday, April 27, 1993
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 21, 1992

Trademark Statements


Goods and Servicescanine lymphoma monoclonal antibody
Pseudo MarkCL MAB 231

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, January 31, 2004
Primary Code005
First Use Anywhere DateTuesday, August 27, 1991
First Use In Commerce DateTuesday, August 27, 1991

Trademark Owner History


Party NameSynbiotics Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92127

Party NameSynbiotics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92127

Party NameSynbiotics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92127

Trademark Events


Event DateEvent Description
Saturday, January 31, 2004CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, August 1, 2002TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 11, 1998REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 26, 1998REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, April 27, 1993REGISTERED-PRINCIPAL REGISTER
Saturday, March 6, 1993ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 26, 1993STATEMENT OF USE PROCESSING COMPLETE
Monday, December 21, 1992USE AMENDMENT FILED
Tuesday, October 13, 1992NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 1992PUBLISHED FOR OPPOSITION
Friday, June 19, 1992NOTICE OF PUBLICATION
Wednesday, April 8, 1992APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 6, 1992CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 21, 1992NON-FINAL ACTION MAILED
Wednesday, December 18, 1991ASSIGNED TO EXAMINER

Related Keywords


antibody monoclonal lymphoma canine